A proud Huntington’s disease gene carrier’s message to his 'miracle baby' daughter on her senior year in college, Kenneth P. Serbin
At Risk for Huntington's Disease

Bidding farewell to my ‘mind coach,’ a major ally in my fight to avoid Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

CRISPR, curing Huntington’s disease, and humanity’s future in Isaacson's 'Code Breaker', Kenneth P. Serbin
At Risk for Huntington's Disease

‘The first at-bat is never a grand slam’: how Huntington's disease drug research has matured with the Roche and Wave setbacks, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Inequality is unsustainable’: a view of the quest for Huntington's disease treatments from the Global South, Kenneth P. Serbin
At Risk for Huntington's Disease

Overcoming a ‘heartbreaking’ moment for the Huntington's disease cause (Coping with disappointing clinical trial results – Part I), Kenneth P. Serbin
At Risk for Huntington's Disease

With PROOF-HD in the lead, the Huntington’s disease drug pipeline is still 'full of hope' (Coping with disappointing clinical trial results – Part II), Kenneth P. Serbin
At Risk for Huntington's Disease

Roche confirms tominersen as ineffective, while Triplet provides key details for trial of drug to slow major driver of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Blog article No. 300: who exactly is Gene Veritas?, Kenneth P. Serbin
At Risk for Huntington's Disease

Tough news for Huntington’s, other neurological disease patients: Roche halts dosing in historic clinical trials on signs of inefficacy, Kenneth P. Serbin
At Risk for Huntington's Disease

My arduous, lucky, and enlightening journey since my mother's death from Huntington's disease 15 years ago, Kenneth P. Serbin
At Risk for Huntington's Disease

Getting the COVID-19 vaccine and a new exercise bike to keep stable in the fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

A veteran neurologist’s book offers tools for navigating the 'turbulent world' of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Annual Huntington Study Group meeting reveals an HD community energized to aid families, develop treatments, Kenneth P. Serbin
At Risk for Huntington's Disease

Happy Thanksgiving! And hail to the pharmaceutical and biotech industries – and the scientists!, Kenneth P. Serbin
At Risk for Huntington's Disease

After a horrid year, free streaming of ‘Dancing at the Vatican' is an inspirational gift and a call to aid Huntington's disease families, Kenneth P. Serbin
At Risk for Huntington's Disease

Triplet Therapeutics aims to transform the approach to treating Huntington's disease, similar disorders, Kenneth P. Serbin
At Risk for Huntington's Disease

In this electoral season, let’s highlight our natural role as caregivers and support care professionals, Kenneth P. Serbin
At Risk for Huntington's Disease

Wonder if you’ll get Huntington’s disease? Preparing for the big, 'intensely personal' decision to undergo predictive testing, Kenneth P. Serbin
At Risk for Huntington's Disease

In the pandemic, we need to rediscover patience and grasp our responsibility, Kenneth P. Serbin
At Risk for Huntington's Disease

Combatting the pandemic, Roche also forges ahead with critical Phase 3 Huntington's disease clinical trial, Kenneth P. Serbin
At Risk for Huntington's Disease

CHDI head scientist Pacifici: ‘hang on in the learning roller coaster ride of Huntington's disease clinical trials', Kenneth P. Serbin
At Risk for Huntington's Disease

In times of crisis, Huntington’s and other chronic disease communities provide examples of fortitude, Kenneth P. Serbin
At Risk for Huntington's Disease

Giving back during the COVID-19 pandemic, Kenneth P. Serbin
At Risk for Huntington's Disease

I’m a Huntington’s disease gene carrier at age 60, so why haven't I developed symptoms yet?, Kenneth P. Serbin
At Risk for Huntington's Disease

Striving to overcome the doom of Huntington’s disease, Kenneth P. Serbin
At Risk for Huntington's Disease

At Therapeutics Conference, landmark study of young gene carriers highlights how Huntington's disease researchers seek to solve critical puzzles, Kenneth P. Serbin
At Risk for Huntington's Disease

Planning a ‘Dancing at the Vatican’ screening to celebrate the global Huntington's disease community's journey, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Navigating’ the Huntington’s disease community towards crucial clinical trials, Kenneth P. Serbin
At Risk for Huntington's Disease

An ‘electric,’ inspiring Thanksgiving for the Huntington's disease community, Kenneth P. Serbin
At Risk for Huntington's Disease

As range of possible therapies grows, CHDI expands efforts to defeat Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Are we failing to stop Huntington’s disease by ignoring 'natural' remedies, alternative therapies, and repurposed drugs?, Kenneth P. Serbin
At Risk for Huntington's Disease

Factor-H partners with Latin American organizations to aid destitute Huntington's disease families, seeks to expand support, Kenneth P. Serbin
At Risk for Huntington's Disease

What if we could turn off the cause of Huntington’s disease?, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Dancing at the Vatican,’ about Huntington’s families' remarkable papal audience, premieres July 27, Kenneth P. Serbin
At Risk for Huntington's Disease

Are pre-existing conditions returning, and Obamacare ending?, Kenneth P. Serbin
At Risk for Huntington's Disease

Roche restarts redesigned Phase 3 Huntington’s disease trial, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Let’s Talk About Huntington’s Disease’: 2019 HD Awareness Month kicks off, Kenneth P. Serbin
At Risk for Huntington's Disease

My Huntington’s disease sister – and a hero who strives for the unthinkable, Kenneth P. Serbin
At Risk for Huntington's Disease

Comedian Rod Man’s heartfelt speech, Ramona Johnston's death remind us of urgent need to cure Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

‘We can now fear Huntington’s disease less’: reflections on the 14th Therapeutics Conference, Kenneth P. Serbin
At Risk for Huntington's Disease

Roche ramps up Huntington’s disease clinical trial for early-to mid-stage patients, considers ways to expand research, Kenneth P. Serbin
At Risk for Huntington's Disease

Roche: less frequent dosing for Phase 3 Huntington's clinical trial, easing burden on patients, Kenneth P. Serbin
At Risk for Huntington's Disease

Continued progress, but also caution, in the fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

CHDI’s chief scientist: ‘Not a time for the Huntington's community to rest its laurels', Kenneth P. Serbin
At Risk for Huntington's Disease

A friend of the Huntington’s community receives award for HD article in influential Brazilian magazine, Kenneth P. Serbin
At Risk for Huntington's Disease

Hacking humans, upgrading Homo sapiens: the role of the Huntington's disease community and the consequences for life, Kenneth P. Serbin
At Risk for Huntington's Disease

Building solidarity in disease communities’ quest for better care and treatments: a conversation with a young tennis award-winner, Kenneth P. Serbin
At Risk for Huntington's Disease

Roche announces U.S., Canada sites for Phase 3 clinical trial of Huntington's disease drug, Kenneth P. Serbin
At Risk for Huntington's Disease

Roche announces first sites for key Huntington’s disease observational study, Kenneth P. Serbin
At Risk for Huntington's Disease

This Thanksgiving, appreciating stable health and new plans for Huntington's disease advocacy, Kenneth P. Serbin
At Risk for Huntington's Disease

Roche Phase 3 clinical trial for Huntington’s disease gene-slicing drug to enroll volunteers in early 2019, Kenneth P. Serbin
At Risk for Huntington's Disease

Unpacking GENERATION HD1, the Roche Phase 3 Huntington's disease clinical trial, Kenneth P. Serbin
At Risk for Huntington's Disease

In Harriet’s tragic death, the vulnerability caused by Huntington's disease – but also the story of a beautiful soul, Kenneth P. Serbin
At Risk for Huntington's Disease

Free from the threat of Huntington’s disease, our 'miracle baby' turns 18, Kenneth P. Serbin
At Risk for Huntington's Disease

Nora Guthrie: we’re all ‘hoping machines’ in the fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

New Ionis data show positive trends in clinical measures of Huntington's disease drug trial volunteers, Kenneth P. Serbin
At Risk for Huntington's Disease

The best news for the Huntington's disease community since the discovery of the gene: Ionis trial data revealed, Roche confirms jump to Phase 3, Kenneth P. Serbin
At Risk for Huntington's Disease

In chronicling the quest to cure Huntington’s disease, a whirlwind of emotions, Kenneth P. Serbin
At Risk for Huntington's Disease

Roche gears up for pivotal Phase 3 Huntington’s disease gene-slicing clinical trial, Kenneth P. Serbin
At Risk for Huntington's Disease

Faith in each other: sticking together through the challenges of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

CHDI's 13th conference promises some good news for the Huntington's disease community, Kenneth P. Serbin
At Risk for Huntington's Disease

Overflow audience at 13th annual Huntington's Disease Therapeutics Conference, Kenneth P. Serbin
At Risk for Huntington's Disease

Ionis drug successfully reduces toxic Huntington’s disease protein, paving way for Phase 2 trial of effect on patients, Kenneth P. Serbin
At Risk for Huntington's Disease

Ionis scientists provide initial assessment of successful Phase 1/2a Huntington's disease trial and discuss next steps, Kenneth P. Serbin
At Risk for Huntington's Disease

A time for hope: HDSA’s 50th anniversary, a record-setting gala, and the impending release of highly anticipated clinical trial results, Kenneth P. Serbin
At Risk for Huntington's Disease

Advocacy in the workplace: raising awareness about Huntington's disease and brain health, Kenneth P. Serbin
At Risk for Huntington's Disease

Ionis Huntington’s disease drug a step closer to a critical Phase 2 study, Kenneth P. Serbin
At Risk for Huntington's Disease

Fear not, Huntington’s disease families – Pope Francis has our backs, Kenneth P. Serbin
At Risk for Huntington's Disease

Pope Francis declares: Huntington’s disease should be 'hidden no more', Kenneth P. Serbin
At Risk for Huntington's Disease

Francis made a day of ‘superlatives’ for the Huntington's disease community, says event co-organizer, Kenneth P. Serbin
At Risk for Huntington's Disease

Join the Facebook Live event (soon!) on Pope Francis's historic audience with Huntington's disease families, Kenneth P. Serbin
At Risk for Huntington's Disease

Preparing for the meeting with Pope Francis, a heartening milestone in the Huntington's disease movement, Kenneth P. Serbin
At Risk for Huntington's Disease

Pope Francis I to meet with victims of Huntington’s disease, a first for a world leader, Kenneth P. Serbin
At Risk for Huntington's Disease

Banning college football: an urgent objective for brain health advocates, Kenneth P. Serbin
At Risk for Huntington's Disease

Staying when the Chargers leave: a leading Huntington's disease advocate sets a gutsy, loving example, Kenneth P. Serbin
At Risk for Huntington's Disease

Passing on the Huntington’s disease advocacy baton to the next generation, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Crying a few million tears’ for the fallen victims of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

This Thanksgiving, let’s show gratitude for disease researchers and drug hunters, Kenneth P. Serbin
At Risk for Huntington's Disease

Ionis Phase I Huntington’s disease trial at halfway mark: 'No surprises so far' means good news, Kenneth P. Serbin
At Risk for Huntington's Disease

Dreams for a better future: an opportunity we Huntington's disease people and our families are denied, Kenneth P. Serbin
At Risk for Huntington's Disease

A family united against Huntington’s disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Upbeat Huntington’s disease film, featuring undaunted family, aims for 10 million views, Kenneth P. Serbin
At Risk for Huntington's Disease

Just living life: a focus on what matters most in coping with the risk of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

From sheepish to self-assured in the fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Billboards: an old – but also new – way of projecting the Huntington's cause, Kenneth P. Serbin
At Risk for Huntington's Disease

The little things that are really big: caregiving in families with Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Chief Huntington’s disease drug hunter: ‘every confidence first treatments' in the works, Kenneth P. Serbin
At Risk for Huntington's Disease

A key Huntington’s disease trial remedy gets Orphan Drug Designation, as yet another young life is cut short, Kenneth P. Serbin
At Risk for Huntington's Disease

Defeating Huntington’s disease starts with taking care of yourself and joining Enroll-HD, Kenneth P. Serbin
At Risk for Huntington's Disease

How to make law enforcement a friend – not a foe – of people with Huntington's disease (and other disabilities), Kenneth P. Serbin
At Risk for Huntington's Disease

‘Twas the morning after Christmas – and Huntington's disease hit us like a ton of bricks, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Concussion’: advocating for the truth about brain diseases, Kenneth P. Serbin
At Risk for Huntington's Disease

Might I finally take part in a Huntington’s disease clinical trials? An update on the latest research, Kenneth P. Serbin
At Risk for Huntington's Disease

With more Huntington’s disease clinical trials, volunteers need help with comparison shopping, Kenneth P. Serbin
At Risk for Huntington's Disease

At-risk Angels pitcher Joe Smith at Huntington’s fundraiser: 'I'd give every dime I have for a cure', Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington’s disease patients get first dosing in historic Isis Pharmaceuticals' gene-silencing drug trial, Kenneth P. Serbin
At Risk for Huntington's Disease

New film unmasks the raw reality of Huntington’s disease, Kenneth P. Serbin
At Risk for Huntington's Disease

As he lay dying: FDA and Huntington’s disease families meet to ponder potential treatments, Kenneth P. Serbin
At Risk for Huntington's Disease

At key FDA meeting, Huntington's disease community insists on faster search for treatments, Kenneth P. Serbin
At Risk for Huntington's Disease

Reinforcing the global fight against Huntington’s disease: a visit to Brazil and a reminder of our common struggles, Kenneth P. Serbin
At Risk for Huntington's Disease

Isis Pharmaceuticals launches historic clinical trial to silence Huntington's disease gene, Kenneth P. Serbin
At Risk for Huntington's Disease

Unraveling the mysteries of the mitochondria in Huntington's disease – and getting fast, clear, and useful results from research studies, Kenneth P. Serbin
At Risk for Huntington's Disease

Deciphering signals from Huntington’s disease brains in the search for treatments, Kenneth P. Serbin
At Risk for Huntington's Disease

The search for Huntington's disease treatments is indeed 'rocket science' – and we can all help build the rocket, Kenneth P. Serbin
At Risk for Huntington's Disease

Overcoming the Fear of the Lion: A Courageous Film About Genetic Testing and Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Engaging a ‘scared population’ of Huntington’s disease families by respecting their journeys, Kenneth P. Serbin
At Risk for Huntington's Disease

The Huntington’s disease community can’t afford to lose momentum, Kenneth P. Serbin
At Risk for Huntington's Disease

The precious participation of the Huntington’s disease community in the quest for treatments: a report on the 2015 HD Therapeutics Conference, Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington’s disease patients ‘feel better’ after takin Auspex compound to control chorea in clinical trial, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Darkness replaced by hope and light’: taking stock of Huntington's disease research, Kenneth P. Serbin
At Risk for Huntington's Disease

‘None of us are free until we are all free’: science and solidarity at the 10th Annual Huntington's Disease Therapeutic Conference, Kenneth P. Serbin
At Risk for Huntington's Disease

Police killing of man with Huntington’s disease spotlights need for affected families to emphasize proactive, dignified approach, Kenneth P. Serbin
At Risk for Huntington's Disease

Fighting – and writing – to stay healthy: ten years of 'At Risk for Huntington's Disease', Kenneth P. Serbin
At Risk for Huntington's Disease

Sharon’s inspirational journey with CrossFit in the fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Six cool L.A. ladies ‘bare the truth’ about Huntington's disease, highlighting an exceptionally creative year for advocacy, Kenneth P. Serbin
At Risk for Huntington's Disease

Another major supplement, creatine, proven ineffective in the fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Moving toward a potential treatment: Isis, CHDI researchers outline upcoming Huntington's disease gene-silencing trials, Kenneth P. Serbin
At Risk for Huntington's Disease

Outrage over video of police’s rough handling of man with Huntington's disease spurs calls for justice, awareness, Kenneth P. Serbin
At Risk for Huntington's Disease

Making the threat of Huntington’s disease ‘small stuff', Kenneth P. Serbin
At Risk for Huntington's Disease

Bidding farewell to CoQ10: a long-studied supplement proves ineffective in the fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

News flash: Isis and Roche hope to start Huntington's gene-silencing trials in first half of 2015, Kenneth P. Serbin
At Risk for Huntington's Disease

Can we afford the costs of orphan disease treatments?, Kenneth P. Serbin
At Risk for Huntington's Disease

Fear of onset: the inescapable reality of the Huntington's disease gene carrier, Kenneth P. Serbin
At Risk for Huntington's Disease

New California stem cell chief stresses speed and efficiency in search for treatments, Kenneth P. Serbin
At Risk for Huntington's Disease

Fathoming Huntington’s disease, genetic testing and the biotechnological era in an academic setting, Kenneth P. Serbin
At Risk for Huntington's Disease

Support from unaffected relatives makes big difference in fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Anonymous donors, confidentiality, and how we all must work to defeat Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Reshaping my career and life in the face of Huntington's disease (and a note of hope), Kenneth P. Serbin
At Risk for Huntington's Disease

Woody Guthrie, Huntington’s disease, and our duty to improve caregiving, Kenneth P. Serbin
At Risk for Huntington's Disease

After a Social Security setback, HDSA steps up advocacy on Huntington's disability criteria, Kenneth P. Serbin
At Risk for Huntington's Disease

‘It’s really getting real’: payoffs in the effort to treat Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

What’s in a name? How Huntington’s disease gene carriers are seen by themselves and others, Kenneth P. Serbin
At Risk for Huntington's Disease

Proof of heaven? My ongoing search for the meaning of Huntington's disease in life and death, Kenneth P. Serbin
At Risk for Huntington's Disease

To take, or not to take, unproven supplements in the fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Accentuating the positive: Olympic medalist Sarah Winckless's strategy against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Game-changers in the fight against disease: a report from the World Cup Cell Summit, Kenneth P. Serbin
At Risk for Huntington's Disease

Riding the advocacy revolution: stem cell activists. the future of CIRM, and public awareness, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Alive and Well’ captures struggle against untreatable brain disorder, Kenneth P. Serbin
At Risk for Huntington's Disease

Creating a Christmas memory for a Huntington’s family, Kenneth P. Serbin
At Risk for Huntington's Disease

It’s playoff time – and a reminder that brain health comes first, Kenneth P. Serbin
At Risk for Huntington's Disease

One year out of the terrible, lonely Huntington’s disease closet, Kenneth P. Serbin
At Risk for Huntington's Disease

Braving bioethical challenges: the importance of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

A Huntington’s Thanksgiving message: gratitude for health and the ability to work, Kenneth P. Serbin
At Risk for Huntington's Disease

Hope, cutting-edge science, and poignant moments at the World Congress on Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease

The end of fear and exclusion: informing my health insurance plan about the risk of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Tired of waiting,’ Huntington’s disease families engrossed in efforts to conduct clinical trials, Kenneth P. Serbin
At Risk for Huntington's Disease

Advocacy meets science and medicine: personal enrichment and a coping mechanism for Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Heading to Rio for the 2013 World Congress on Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Reaching out to the ‘HD family’ at the World Congress on Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease

A gene-positive dad’s reflections on Huntington’s disease, parenthood, and the fragility of life, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Predicting’ Huntington’s disease in the heartland, Kenneth P. Serbin
At Risk for Huntington's Disease

Going with the flow of time, Kenneth P. Serbin
At Risk for Huntington's Disease

Fighting for the option to care for Huntington’s disease patients at home, Kenneth P. Serbin
At Risk for Huntington's Disease

Memories of genetic testing: from my mom to Angelina Jolie, Kenneth P. Serbin
At Risk for Huntington's Disease

Do we need to shock the world to strengthen the Huntington's disease cause, Kenneth P. Serbin
At Risk for Huntington's Disease

Strangling of patient in nursing home a shuddering reminder of subpar care for Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Brazil’s big place on the Huntington’s disease map, Kenneth P. Serbin
At Risk for Huntington's Disease

Quickening the pace towards a Huntington’s disease gene-silencing clinical trials: pharma giant Roche, Isis enter partnership, Kenneth P. Serbin
At Risk for Huntington's Disease

Feeling the hope, Kenneth P. Serbin
At Risk for Huntington's Disease

A key new ally in the search for Huntington’s disease treatments, Kenneth P. Serbin
At Risk for Huntington's Disease

The Brain Activity Map Project: short- and long-term prospects for Huntington's disease research, Kenneth P. Serbin
At Risk for Huntington's Disease

Big decisions while facing the threat of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

‘No Marine deserted on the battlefield’: two surviving spouses join forces to speed the defeat of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Pope Benedict XVI’s resignation: a witness to aging, a signal for a new bioethics, Kenneth P. Serbin
At Risk for Huntington's Disease

The return of the Huntington’s whirlwind, Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington's disease and the perils of adoption, Kenneth P. Serbin
At Risk for Huntington's Disease

Junior Seau, Super Sunday, and our most important natural resource, Kenneth P. Serbin
At Risk for Huntington's Disease

The incredible lightness – and responsibility – of exiting the Huntington's closet, Kenneth P. Serbin
At Risk for Huntington's Disease

The gifts, Kenneth P. Serbin
At Risk for Huntington's Disease

The definitive step out of the Huntington’s closet, Kenneth P. Serbin
At Risk for Huntington's Disease

Designing the best drug possible to defeat Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

HDSA’s renewed commitment to critical research, Kenneth P. Serbin
At Risk for Huntington's Disease

Hope of clinical trials creates new, proactive outlook on Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

SuperTerry destroys the evil monster Huntington’s disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Lifting Huntington’s families’ spirits with the promise of clinical trials, Kenneth P. Serbin
At Risk for Huntington's Disease

California stem cell agency approves $19 million clinical trial project as Huntington's disease families 'change the course of science', Kenneth P. Serbin
At Risk for Huntington's Disease

Playing in the fourth quarter of life as Huntington's disease looms, Kenneth P. Serbin
At Risk for Huntington's Disease

Yale’s partnership against Huntington’s disease: an alumnus reconnects and finds hope as scientists pursue 'Viagra for the brain' and other solutions, Kenneth P. Serbin
At Risk for Huntington's Disease

The wholehearted embrace: my first HDSA convention, Kenneth P. Serbin
At Risk for Huntington's Disease

A Compassionate Allowance, and faster Social Security benefits, for the juvenile Huntington's disease community: a key step for advocacy, Kenneth P. Serbin
At Risk for Huntington's Disease

The Team Hope Walk: reinforcing the first line of defense against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

From a paralyzed genius, lessons of determination and caregiving for the Huntington's community, Kenneth P. Serbin
At Risk for Huntington's Disease

Top researcher: ‘Genuine optimism’ about treatments for Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

The first dose is hope: moving towards treatments for Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

A new, more holistic view of Huntington’s disease: the systems/P4 approach, Kenneth P. Serbin
At Risk for Huntington's Disease

The quandary of denial in the Huntington’s disease community (Part I), Kenneth P. Serbin
At Risk for Huntington's Disease

The quandary of denial in the Huntington’s disease community (Part II), Kenneth P. Serbin
At Risk for Huntington's Disease

It’s time for the Huntington’s community to speak out - and HDSA is listening, Kenneth P. Serbin
At Risk for Huntington's Disease

Striving for brave new brains, Kenneth P. Serbin
At Risk for Huntington's Disease

Seven years of striving for a realistic and unapologetic view of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Let’s turn grief for ‘HD Angels’ into new impetus for the Huntington's cure, Kenneth P. Serbin
At Risk for Huntington's Disease

Advocacy pays off: Huntington’s disease stem-cell research advances in California, Kenneth P. Serbin
At Risk for Huntington's Disease

To strive or to chill? Seeking balance in the fight against Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

An angel fighting for the cure (Huntington’s disease and abortion - Part I), Kenneth P. Serbin
At Risk for Huntington's Disease

Kate's untested baby (Huntington’s disease and abortion - Part II), Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington’s disease in the news and entertainment media - Part II: A suicide on TV, Kenneth P. Serbin
At Risk for Huntington's Disease

Finding America’s passion: the NFL and Huntington’s disease, Kenneth P. Serbin
At Risk for Huntington's Disease

An HD Thanksgiving toast, Kenneth P. Serbin
At Risk for Huntington's Disease

The Holy Grail of Huntington's disease research: the gene-positive, drug trials, and treatments, Kenneth P. Serbin
At Risk for Huntington's Disease

Making sense of Huntington’s organizations, and a call for unity, Kenneth P. Serbin
At Risk for Huntington's Disease

BDNF and ‘Neurobics’: building a ‘beautiful mind’ against Huntington's, Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington’s disease and the financial jitters, Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington’s disease in the news and entertainment media - Part I: Stigma and genetic testing, Kenneth P. Serbin
At Risk for Huntington's Disease

One Man's Story: Entering the Light, Kenneth P. Serbin
At Risk for Huntington's Disease

Waiting for symptoms: How long can I hang on?, Kenneth P. Serbin
At Risk for Huntington's Disease

Do-or-die time for Huntington’s clinical trials, Kenneth P. Serbin
At Risk for Huntington's Disease

Some reflections on being named 'HDSA Person of the Year', Kenneth P. Serbin
At Risk for Huntington's Disease

No time for complacency: get ready for HD clinical trials, Kenneth P. Serbin
At Risk for Huntington's Disease

The Huntington's disease high-wire act, Kenneth P. Serbin
At Risk for Huntington's Disease

Face to face at the Huntington's disease convention, Kenneth P. Serbin
At Risk for Huntington's Disease

Bin Laden and HD, Kenneth P. Serbin
At Risk for Huntington's Disease

The Huntington’s community rising and converging, Kenneth P. Serbin
At Risk for Huntington's Disease

Holding the potential cure in my hand, Kenneth P. Serbin
At Risk for Huntington's Disease

S.O.S. for Huntington's disease families, and an important bill in Congress, Kenneth P. Serbin
At Risk for Huntington's Disease

The faceless faces of Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Let’s fix the law to help Huntington’s families, Kenneth P. Serbin
At Risk for Huntington's Disease

The shadow career, Kenneth P. Serbin
At Risk for Huntington's Disease

The diary of a Huntington's disease activist, Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington’s support group: seeking solidarity, fighting denial, Kenneth P. Serbin
At Risk for Huntington's Disease

A cascade of emotions about Huntington’s disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington’s disease, loneliness, and love, Kenneth P. Serbin
At Risk for Huntington's Disease

Unmasking Gene Veritas: a Huntington's disease activist goes public, Kenneth P. Serbin
At Risk for Huntington's Disease

‘Drug hunters’ bring hope to Huntington’s families, Kenneth P. Serbin
At Risk for Huntington's Disease

Coming down from coming out: recharging the activism batteries, Kenneth P. Serbin
At Risk for Huntington's Disease

Memories of the DNA car, Kenneth P. Serbin
At Risk for Huntington's Disease

Feeling like an alien: going public about Huntington's, Kenneth P. Serbin
At Risk for Huntington's Disease

Globalizing the fight against Huntington's, Kenneth P. Serbin
At Risk for Huntington's Disease

Vertex and the new wave of Huntington’s research, Kenneth P. Serbin
At Risk for Huntington's Disease

The mission of a lifetime, Kenneth P. Serbin
At Risk for Huntington's Disease

The best Christmas gift of all, Kenneth P. Serbin
At Risk for Huntington's Disease

Enjoying the life we have left, Kenneth P. Serbin
At Risk for Huntington's Disease

Losing control, seeking connections, Kenneth P. Serbin
At Risk for Huntington's Disease

An expedition to the brain, Kenneth P. Serbin
At Risk for Huntington's Disease

Living in limbo, Kenneth P. Serbin
At Risk for Huntington's Disease

More to lose than ever', Kenneth P. Serbin
At Risk for Huntington's Disease

Out of the closet and on to the cure, Kenneth P. Serbin
At Risk for Huntington's Disease

Traveling across America, togetherness and memories, Kenneth P. Serbin
At Risk for Huntington's Disease

My friend, the fast lane, Kenneth P. Serbin
At Risk for Huntington's Disease

God, Huntington's disease and the meaning of life, Kenneth P. Serbin
At Risk for Huntington's Disease

Charting new territory: going public about HD, Kenneth P. Serbin
At Risk for Huntington's Disease

Care versus cure: we can progress in both, Kenneth P. Serbin
At Risk for Huntington's Disease

A perfect day: the sunset of a meaningful life, Kenneth P. Serbin
At Risk for Huntington's Disease

Dad, could you get HD?', Kenneth P. Serbin
At Risk for Huntington's Disease

The point of no return, Kenneth P. Serbin
At Risk for Huntington's Disease

Ten reasons to cure HD, Kenneth P. Serbin
At Risk for Huntington's Disease

Aiming for HD clinical trials, Kenneth P. Serbin
At Risk for Huntington's Disease

Good-bye, pre-existing conditions!, Kenneth P. Serbin
At Risk for Huntington's Disease

A Super Sunday HD story, Kenneth P. Serbin
At Risk for Huntington's Disease

A restless soul at the HD research meeting, Kenneth P. Serbin
At Risk for Huntington's Disease

Squeezing in the life, Kenneth P. Serbin
At Risk for Huntington's Disease

When the pain brings a smile, Kenneth P. Serbin
At Risk for Huntington's Disease

Telling the truth about a disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Feel the love: a family faces juvenile Huntington’s disease, Kenneth P. Serbin
At Risk for Huntington's Disease

No time for fear, Kenneth P. Serbin
At Risk for Huntington's Disease

Smelling the flowers at Thanksgiving, Kenneth P. Serbin
At Risk for Huntington's Disease

An experiment and a death, Kenneth P. Serbin
At Risk for Huntington's Disease

My new profession: HD activist, Kenneth P. Serbin
At Risk for Huntington's Disease

Creating hope, Kenneth P. Serbin
At Risk for Huntington's Disease

In the midst of the hurricane, Kenneth P. Serbin
At Risk for Huntington's Disease

The unending 'thank you', Kenneth P. Serbin
At Risk for Huntington's Disease

Ten years after the test, Kenneth P. Serbin
At Risk for Huntington's Disease

Pondering an exit from the HD closet, Kenneth P. Serbin
At Risk for Huntington's Disease

Imagining a world without Huntington's, Kenneth P. Serbin
At Risk for Huntington's Disease

A life-or-death walk into the future, Kenneth P. Serbin
At Risk for Huntington's Disease

Great reasons to be a guinea pig, Kenneth P. Serbin
At Risk for Huntington's Disease

A new attitude about Huntington’s disease, Kenneth P. Serbin
At Risk for Huntington's Disease

The time is ripe, Kenneth P. Serbin
At Risk for Huntington's Disease

HD: hurtling towards death, Kenneth P. Serbin
At Risk for Huntington's Disease

To flee or to fight, Kenneth P. Serbin
At Risk for Huntington's Disease

In a time of crisis, the best investment of all, Kenneth P. Serbin
At Risk for Huntington's Disease

A holiday message: hope for the forsaken of Huntington's, Kenneth P. Serbin
At Risk for Huntington's Disease

Our economic comeback and the cure industry, Kenneth P. Serbin
At Risk for Huntington's Disease

A Huntington's warrior lays down his shield, Kenneth P. Serbin
At Risk for Huntington's Disease

Disease, denial, and support: the many kinds of family, Kenneth P. Serbin
At Risk for Huntington's Disease

The roots of our stigma, Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington's disease, destroyer of families, Kenneth P. Serbin
At Risk for Huntington's Disease

Time for optimism: a cure for Huntington's could be near, Kenneth P. Serbin
At Risk for Huntington's Disease

Observing the cure in progress, Kenneth P. Serbin
At Risk for Huntington's Disease

Building a ‘laser-guided missile’ to attack Huntington's disease, Kenneth P. Serbin
At Risk for Huntington's Disease

Keeping calm in the face of Huntington's, Kenneth P. Serbin
At Risk for Huntington's Disease

Stem cells: the dawn of a new era for Huntington’s disease research, Kenneth P. Serbin
At Risk for Huntington's Disease

The complications and stress of success, Kenneth P. Serbin
At Risk for Huntington's Disease

Dreaming of victory, Kenneth P. Serbin
At Risk for Huntington's Disease

Uncertainty and a steadfast spouse, Kenneth P. Serbin
At Risk for Huntington's Disease

Testing a new service, Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington's makes page one, Kenneth P. Serbin
At Risk for Huntington's Disease

Coming together, Kenneth P. Serbin
At Risk for Huntington's Disease

Handling the news, Kenneth P. Serbin
At Risk for Huntington's Disease

Mourning mom, Kenneth P. Serbin
At Risk for Huntington's Disease

Saying good-bye to Mom, Kenneth P. Serbin
At Risk for Huntington's Disease

Should Mom get a feeding tube?, Kenneth P. Serbin
At Risk for Huntington's Disease

A Thanksgiving visit: a time to reflect on HD, Kenneth P. Serbin
At Risk for Huntington's Disease

A Huntington's Christmas story: ten years of wondering, Kenneth P. Serbin
At Risk for Huntington's Disease

Dr. Martha Nance to do live chat on HD, Kenneth P. Serbin
At Risk for Huntington's Disease

An uncertain journey along the genetic trail, Kenneth P. Serbin
At Risk for Huntington's Disease

Planning for Mom's move to a nursing home, Kenneth P. Serbin
At Risk for Huntington's Disease

Preparing for a lonely day, Kenneth P. Serbin
At Risk for Huntington's Disease

The ups and downs of waiting for a cure, Kenneth P. Serbin
At Risk for Huntington's Disease

HD's financial devastation, Kenneth P. Serbin
At Risk for Huntington's Disease

What is wrong with Grandma?, Kenneth P. Serbin
At Risk for Huntington's Disease

Seeing Mom (Part I): falling down, Kenneth P. Serbin
At Risk for Huntington's Disease

Seeing Mom (Part II): a family's emotions, Kenneth P. Serbin
At Risk for Huntington's Disease

Giving up my dreams, Kenneth P. Serbin
At Risk for Huntington's Disease

At risk, but not alone, Kenneth P. Serbin
At Risk for Huntington's Disease

To go – or not to go – public, Kenneth P. Serbin
At Risk for Huntington's Disease

Huntington's disease: an early date with mortality, Kenneth P. Serbin
At Risk for Huntington's Disease

Learning about HD, Kenneth P. Serbin
At Risk for Huntington's Disease

Overcoming HD's tyranny of time, Kenneth P. Serbin
At Risk for Huntington's Disease